Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The American Journal of the Medical Sciences|September 21, 2002
Obesity, physical inactivity, and risk for cardiovascular diseasePatricia M Dubbert, Teresa Carithers, Anne E Sumner, et al.Clinical Lung Cancer|June 14, 2011
A phase II study of higher dose weekly topotecan in relapsed small-cell lung cancerDavid R Spigel, F Anthony Greco, Howard A Burris, et al.The American Journal of Cardiology|January 27, 2005
Relation of aortic valve sclerosis to risk of coronary heart disease in African-AmericansHerman A Taylor, Bobby L Clark, Robert J Garrison, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junctionDavid R Spigel, F Anthony Greco, Anthony A Meluch, et al.Clinical Breast Cancer|November 26, 2009
A phase II randomized crossover study of liposomal doxorubicin versus weekly docetaxel in the first-line treatment of women with metastatic breast cancerDenise A Yardley, Howard A Burris, David R Spigel, et al.Cancer|June 22, 2010
Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research ConsortiumJohn D Hainsworth, Jeffrey R Infante, David R Spigel, et al.Cancer Journal (Sudbury, Mass.)|February 19, 2010
Paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon Oncology Research Consortium TrialJohn D Hainsworth, David R Spigel, Bobby L Clark, et al.Clinical Advances in Hematology & Oncology : H&O|September 25, 2010
Phase II trial of FOLFOX6, bevacizumab, and cetuximab in the first-line treatment of metastatic colorectal cancerDavid R Spigel, F Anthony Greco, David Waterhouse, et al.Clinical Lymphoma, Myeloma & Leukemia|March 13, 2010
Brief-duration rituximab/chemotherapy followed by maintenance rituximab in patients with diffuse large B-cell lymphoma who are poor candidates for R-CHOP chemotherapy: a phase II trial of the Sarah Cannon Oncology Research ConsortiumJohn D Hainsworth, Ian W Flinn, David R Spigel, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2010
A phase II trial of carboplatin and weekly topotecan in the first-line treatment of patients with extensive stage small cell lung cancerDavid R Spigel, John D Hainsworth, Jitendra G Gandhi, et al.Pageof 2